Which infections and medications can trigger the development of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in a 35-year-old male?

Medications and Infections That Trigger SJS/TEN in a 35-Year-Old Male

The most common medication triggers for SJS/TEN are allopurinol, carbamazepine, lamotrigine, nevirapine, oxicam NSAIDs, phenobarbital, phenytoin, sulfamethoxazole and other sulfa antibiotics, and sulfasalazine, with sulfamethoxazole carrying the highest risk; when medications cannot be identified as the cause, consider Mycoplasma pneumoniae infection. 1

High-Risk Medications

The UK guidelines provide a definitive list of the most notorious culprit drugs 1:

Anticonvulsants

• Carbamazepine - particularly high risk in Han Chinese populations with HLA-B*1502 genetic marker 2
• Lamotrigine
• Phenytoin
• Phenobarbital

Antibiotics (Highest Overall Risk Category)

• Sulfamethoxazole - carries the highest risk among all antibiotics 3, 4
• Trimethoprim (often combined with sulfamethoxazole) 3, 4
• Other sulfa antibiotics
• Aminopenicillins (amoxicillin, piperacillin) 3
• Cephalosporins (ceftriaxone, cefuroxime, cefotaxime, ceftaroline) 3, 5
• Quinolones 2
• Azithromycin 3
• Vancomycin 3
• Doxycycline 3
• Gentamicin 3
• Daptomycin 5

Anti-Gout Medication

• Allopurinol - particularly dangerous in patients with renal impairment

NSAIDs

• Oxicam NSAIDs specifically (piroxicam, meloxicam)

Antiretroviral

• Nevirapine

Other

• Sulfasalazine

Infectious Triggers

When a causative drug cannot be identified, consider Mycoplasma pneumoniae infection as an alternative etiology 1. Recent evidence expands the infectious causes 6:

Bacterial Infections

• Mycoplasma pneumoniae - can cause "Mycoplasma pneumoniae-associated mucositis," characterized predominantly by mucous membrane involvement with minimal cutaneous lesions, especially in children 1

Viral Infections

Multiple viruses have been implicated 6:

• Herpes simplex virus (HSV) - most commonly associated with erythema multiforme major rather than true SJS/TEN, but can trigger SJS 1, 6
• Influenza virus
• Varicella-zoster virus
• HIV infection
• COVID-19
• Coxsackie virus

Critical Timing Considerations

The latent period between drug initiation and SJS/TEN onset is typically 5-28 days 1. This timing is crucial for causality assessment. If the patient has had a previous reaction to the same drug, the latency period may be shorter 1.

Risk Stratification by Patient Factors

Recent pharmacovigilance data reveals important risk patterns 3:

• Male patients using specific antibiotics may have higher risk than females
• Patients with pneumonia, urinary tract infections, and sepsis have higher risks than those with simple respiratory tract infections
• Age 60-63 years represents the median age for SJS/TEN cases, though your 35-year-old patient is still at risk

Practical Clinical Approach

When evaluating a 35-year-old male with suspected SJS/TEN 1:

1. Obtain comprehensive medication history going back 2 months, including over-the-counter preparations
2. Create a drug timeline using tools like www.drugrash.co.uk to map each medication's start date
3. Calculate drug presence at symptom onset based on half-life, considering any renal/hepatic dysfunction
4. Document previous drug exposures and any prior hypersensitivity reactions
5. If no drug identified, obtain Mycoplasma serology and consider viral testing (HSV, influenza, VZV, HIV) 1

Common Pitfalls

• Do not dismiss recent antibiotic use - even "safe" antibiotics like cephalosporins and macrolides carry risk 3
• Consider drug-drug interactions that may elevate drug levels and increase risk 1
• Remember genetic susceptibility - carbamazepine in Han Chinese populations requires HLA-B*1502 screening 2
• Distinguish from erythema multiforme major - HSV-associated disease is typically recurrent and less severe than drug-induced SJS/TEN 1